Hemophagocytic Lymphohistiocytosis Recruiting Phase 1 Trials for Etoposide (DB00773)

Back to Hemophagocytic Lymphohistiocytosis

Also known as: Hemophagocytic Lymphohistiocytosis (HLH) / Haemophagocytic Lymphohistiocytosis / Hemophagocytic Lymphohistiocytoses / Hemophagocytic Lymphohisticytosis / Hemophagocytic lymphohistiocytosis (disorder) / Lymphohistiocytosis, Hemophagocytic / Primary hemophagocytic lymphohistiocytosis / Primary haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis (disorder) / Familial Hemophagocytic Lymphocytosis / Familial haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis

Indication	Status	Phase
DBCOND0029166 (Hemophagocytic Lymphohistiocytosis)	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05546060	Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH	Treatment	Dexamethasone (DB01234) Etoposide (DB00773) Venetoclax (DB11581)